The aim of this study was to investigate whether an expanded multi-cancer gene panel could identify novel germline variants potentially contributing to melanoma predisposition in patients negative for established high, medium and low-penetrance melanoma genes, and to report the discovery of a novel OBSCN truncating variant in these patients. Here, OBSCN is linked to melanoma.